CompletedNCT01421381
RHODOS Follow-up Single-visit Study
Studying Hereditary optic neuropathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Santhera Pharmaceuticals
- Principal Investigator
- Patrick Chinnery, MDClinical Research Facility
- Enrollment
- 60 enrolled
- Eligibility
- 15-69 years · All sexes
- Timeline
- 2011 – 2011
Study locations (3)
- Hôpital Notre-Dame (CHUM), Montreal, Quebec, Canada
- Friedrich Baur Institut Neurologische Klinik und Poliklinik, München, Germany
- Biomedical Research Centre, The Medical School, Newcastle upon Tyne, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01421381 on ClinicalTrials.govOther trials for Hereditary optic neuropathy
Additional recruiting or active studies for the same condition.